Saturday, July 11, 2026

Drug profile · INN

trovafloxacin

trovafloxacin (TURVEL) is a bacterial dna gyrase inhibitor.

EMA: withdrawn Antiinfectives for systemic use (J01) J01MA13
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — trovafloxacin
Class
Antiinfectives for systemic use (J01)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

trovafloxacin (TURVEL) is a bacterial dna gyrase inhibitor.

Key facts

INN trovafloxacin
Brand TURVEL
Mechanism Bacterial DNA gyrase inhibitor
Target Bacterial DNA gyrase
Therapeutic class Antiinfectives for systemic use (J01)
ATC code J01MA13

Mechanism of action

Bacterial DNA gyrase inhibitor

Primary target: Bacterial DNA gyrase

Approval history

Authority Status Date
EMA withdrawn

Related & competitor drugs

  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. cinoxacin Bacterial DNA gyrase inhibitor
  3. ciprofloxacin Bacterial DNA gyrase inhibitor
  4. ciprofloxacin hydrochloride Bacterial DNA gyrase inhibitor
  5. colistimethate sodium Antiinfectives for systemic use (J01)
  6. covid-19 mrna vaccine Antiinfectives for systemic use (J07)

Frequently asked questions

What is trovafloxacin?

trovafloxacin (TURVEL) is a bacterial dna gyrase inhibitor.

What is the brand name for trovafloxacin?

TURVEL is a marketed brand name for trovafloxacin. Check FDA Drugs@FDA for the current US label holder and prescribing information.